I02-Macromolecular Crystallography
I03-Macromolecular Crystallography
I04-1-Macromolecular Crystallography (fixed wavelength)
|
Open Access
Abstract: The Fc region of immunoglobulin E (IgE-Fc) is an important therapeutic target due to the antibody’s critical role in allergic disorders through interactions with high-affinity (FcεRI) and low-affinity (CD23) receptors. IgE-Fc is known to be conformationally flexible, undergoing large-scale structural changes that modulate receptor binding and downstream biological functions. The mechanistic basis for how ligands induce these allosteric changes is not fully understood. In this study, we investigate structure–function relationships of IgE by characterizing four closely related anti-IgE-Fc Fab fragments with highly conserved sequences that recognize a shared epitope at the base of the Cε2 domain. Despite their sequence similarity, these Fabs exhibit markedly different binding characteristics, stoichiometries, and functional activities. Furthermore, the crystal structures of these four Fab complexes reveal that the bound IgE-Fc adopts a wide range of conformations. These structural differences directly dictate the functional outcomes, ranging from conformations that facilitate FcεRI binding to those that prevent or destabilize receptor interaction. Our findings demonstrate that highly similar antibodies binding to the same epitope on a protein that exhibits significant conformational plasticity can elicit distinct and divergent functional outcomes. This work challenges the conventional antibody discovery paradigm, i.e., “same epitope, same functional outcome,” and highlights the importance of accounting for both the target’s structural flexibility and the resulting functional diversity within antibody selection strategies. This is especially critical when targeting dynamic proteins where allosteric mechanisms are fundamental to function.
|
Sep 2026
|
|
I02-Macromolecular Crystallography
|
Elena
De Vita
,
Adam M.
Thomas
,
Delia
Brustur
,
Montse
Tersa
,
Rita
Petracca
,
Shradda R.
Vadodaria
,
Deborah A.
Briggs
,
Jack W.
Houghton
,
Thomas
Lanyon-Hogg
,
Gregory B.
Craven
,
R. Marc L.
Morgan
,
Alan
Armstrong
,
David J.
Mann
,
Katharine
Lodge
,
Alistair N.
Hume
,
Ernesto
Cota
,
Edward W.
Tate
Diamond Proposal Number(s):
[17221]
Open Access
Abstract: RAB27A and RAB27B are homologous small GTPases that regulate intracellular vesicle trafficking, orchestrating endocytic and exocytic processes that affect cellular communication, immune responses, and the dynamics of the cellular microenvironment. Through their interactions with effector proteins, RAB27A/B plays roles in tumor metastasis and chronic inflammation. However, pharmacological modulation of their activity faces challenges typical of small GTPases, including a lack of well-defined pockets outside the conserved GTP binding site and large RAB27-effector protein–protein interaction (PPI) surfaces. Here, we present the discovery and development of the first cell-active, rationally designed covalent inhibitors of the RAB27-effector interaction, targeting a non-conserved cysteine residue flanking the PPI interface. An electrophile-first biochemical screen led to a novel class of acrylamide covalent inhibitors, and X-ray crystallography structure-guided design led to optimized inhibitors and probes that enantioselectively target RAB27A/B Cys123 in cells. Potency and selectivity were confirmed through biochemical and cellular assays, including chemical proteomics and phenotype recapitulation in melanocytes, alongside a matched inactive enantioprobe control. In contrast, a previously reported compound, Nexinhib-20, was found to be cytotoxic and to exert its activity through non-selective reactivity. This work provides the first toolbox of cell-active chemical probes for RAB27 that can be used in future studies to shed light on the function of this protein and its potential as a therapeutic target.
|
Aug 2026
|
|
I02-Macromolecular Crystallography
I04-1-Macromolecular Crystallography (fixed wavelength)
I04-Macromolecular Crystallography
|
Diamond Proposal Number(s):
[9948]
Open Access
Abstract: Chitoporins (ChiPs) are chitooligosaccharide-specific outer membrane porins found in various Gram-negative bacteria and are critical for marine species that use chitin as a carbon and nitrogen source. Vibrio spp. ChiPs, exemplified by VhChiP from V. harveyi, are trimeric OmpC-like 16-stranded β-barrels with a long pore-confining loop L3 that interacts exclusively with long chain chitooligosaccharides. Here, using crystallography and electrophysiology, we show that two atypical ChiPs, Escherichia coli ChiP (EcChiP) and Serratia marcescens ChiP (SmChiP), are monomeric 18-stranded β-barrels with shorter L3 loops, which display weaker and less selective substrate interactions compared with their Vibrio counterparts. Structure-based phylogenetic analysis of bacterial ChiPs resolves three clades: monomeric ChiPs; clade A, trimeric ChiPs with an N-plug; and clade B, trimeric ChiPs lacking the characterized helical N-plug. These architectural differences likely reflect environmental selection. Marine Vibrio spp., living in chitin-rich environments, possess trimeric ChiPs that enable rapid chitin uptake, whereas soil-borne S. marcescens and multi-habitat E. coli encode monomeric ChiPs that we speculate are more suited to variable substrate availability.
|
Aug 2026
|
|
I02-Macromolecular Crystallography
|
Open Access
Abstract: The twin-arginine translocation (Tat) system is a mechanistically unique protein transport pathway moving folded proteins across membranes. It is found in all domains of life and is essential for bacterial virulence and plant photosynthesis. The membrane proteins, TatA, TatB and TatC form a core complex to which substrate proteins bind, triggering the recruitment of additional TatA protomers to form the transport site. Here we present cryo-electron microscopy structures of the prototypical TatBC complex from Escherichia coli and the atypical complexes from Nitratifactor salsuginis and Myxococcus xanthus in a resting state, alongside TatAC substrate-bound TatBC and TatABC complexes from E. coli in the early stages of transport. These structures demonstrate that substrate proteins associate with the core complex solely through their N-terminal signal peptides. The Tat targeting sequences of the signal peptides make specific contacts with TatC, and the peptide body is clamped by TatB. The core complex contains highly tilted transmembrane helices that drive extreme local membrane thinning. On the basis of our structures and biochemical and functional analyses, we propose a model for the early steps in Tat transport.
|
Jun 2026
|
|
I02-Macromolecular Crystallography
I04-Macromolecular Crystallography
|
Jakob
Bouton
,
Alexis
Bretteville
,
Gary
Tresadern
,
Paul
Shaffer
,
Nigel
Austin
,
Peter
Buijnsters
,
E. Peder
Cedervall
,
Nicolas
Darville
,
Ineke
Fonteyn
,
Joseph
Leenaerts
,
Carolina Martínez
Lamenca
,
Liesbeth
Mertens
,
Daniele
Peeters
,
Adriana I.
Velter
,
Yves Van
Roosbroeck
,
Andreas
Ebneth
,
Jose Manuel
Bartolomé
,
Andrés A.
Trabanco
,
Daniel
Oehlrich
Abstract: Alzheimer’s disease (AD) is a neurodegenerative disorder characterized by extracellular amyloid-β plaque accumulation and intracellular tau neurofibrillary tangles, with tau pathology correlating more closely with cognitive decline. Modulation of tau phosphorylation through the regulation of O-GlcNAcylation, a post-translational modification controlled by O-GlcNAcase (OGA), represents a promising therapeutic strategy. In this study, we report the optimization of a pyrimidine hit identified by high-throughput screening, leading to the discovery and optimization of a novel series of 5-azaindole-based OGA inhibitors. From this series, compound 24 was identified as an in vivo tool candidate that demonstrated a favorable pharmacokinetic profile and measurable brain exposure. Pharmacodynamic studies in murine models demonstrated that compound 24 induced a significant and transient elevation of brain O-GlcNAcylation levels, confirming the in vivo target engagement. These findings underscore the potential of 5-azaindole-based OGA inhibitors as a novel validated chemotype for modulation of O-GlcNAcylation.
|
May 2026
|
|
I02-Macromolecular Crystallography
I03-Macromolecular Crystallography
I24-Microfocus Macromolecular Crystallography
VMXm-Versatile Macromolecular Crystallography microfocus
|
Abstract: Crystallization is a key step in drug purification, offering low cost and facile scalability. The thesis investigates the role of heterogeneous nucleation templates in enhancing crystallization efficiency and controllability with a focus on biopharmaceutical applications, and examines the mechanisms of template-mediated nucleation, crystal growth, and morphology control using carbon-based templates, polymeric hydrogel templates, and microbial bio-templates. The interaction between inorganic salt and proteins was investigated and proteins themselves were also applied as the macromolecular templates. Carbon-based materials, including graphite and graphene oxide (GO), were investigated for their influence on lysozyme crystallization. Graphite reduced nucleation time by 57% compared to those without templates and demonstrated edge adsorption. GO exhibited a nonlinear effect, accelerating nucleation at low lysozyme concentrations (30 mg mL-1) while inhibiting it at higher concentrations (over 50 mg mL-1). Furthermore, a second strategy was pursued using heterogeneous templates based on poly (ethylene glycol) diacrylate (PEGDA) hydrogel microspheres (HMS). In contrast to the adsorption mechanism, the PEGDA HMS acts by releasing precipitant (0- 4 M NaCl) to create localized supersaturation gradients, thereby reducing nucleation time by 79%. Based on the mechanisms of templated crystallization observed in the lysozyme system, this work sought to explore the universality of these effects in inorganic systems critical to biomineralization and disease. The interaction between proteins and inorganic salts was further investigated in two model systems: lithium carbonate (Li'CO') and calcium oxalate (CaOx) with proteins (lysozyme, bovine haemoglobin and mRFP). In both systems, inorganic salt crystals serve as templates that influence subsequent protein adsorption and crystallization, leading to the formation of protein-salt composite crystal structures. Elevated salt concentrations consistently promoted nucleation kinetics. Proteins, however, exhibited complex effects: At low supersaturation, proteins like lysozyme inhibited Li'CO' nucleation by chelating Li'. Conversely, at high supersaturation, proteins self-assemble into oligomers or aggregates, providing additional nucleation sites and accelerating nucleation. In the CaOx system, lysozyme enhanced nucleation across its tested concentration range (0-70 mg mL-1). To bridge our findings on artificial templates to biological contexts, in vivo crystallization is further explored. Inspired by nature, the production of intracellular crystals in Bacillus thuringiensis (Bt) was studied, and its Cry1Ac gene was applied to form a crystal scaffold (CS) as the bio-template to generate crystal nanoparticles in Escherichia coli (E. coli). Through adaptive laboratory evolution (ALE) via serial passaging, we achieved a nearly tenfold increase in protein fluorescence level and produced biologically active nanocrystals with high solubility under alkaline conditions. By integrating heterogeneous nucleation theory with biomimetic strategies, our work elucidates diverse templating mechanisms, including surface, the creation of local supersaturation gradients, and inorganic salt templates. These understandings enable the rational design of templates to control crystallization outcomes. Furthermore, we establish a platform that applying the Cry gene from Bt as the crystal scaffold to function as bio-templates inside cells, demonstrating their potential in high-yield production of bioactive nanocrystals.
|
Apr 2026
|
|
I02-Macromolecular Crystallography
|
Diamond Proposal Number(s):
[31430, 36304]
Open Access
Abstract: Purpose: To characterize structural and biomechanical changes following ex vivo treatment of rabbit sclera with the bacteriochlorophyll derivative WST11 and near-infrared (NIR) light.
Methods: Enucleated left scleras of 10 rabbits were cross-linked by a 20-min topical application of WST11 solution, followed by 30-min NIR irradiation (10 mW/cm2). Paired right eyes served as untreated controls. Scleral tangent modulus and ultimate tensile strength were obtained from tensile strip testing. Collagen molecular-level nanostructure was measured using wide-angle X-ray scattering (WAXS). Scleral fibrillar-level microstructure was assessed using second harmonic generation (SHG) and two-photon fluorescence (TPF) imaging.
Results: WST11/NIR treatment increased scleral tangent modulus by an average of 79% for strains between 1.5% and 3% (p < 0.05), while ultimate tensile strength increased by 140% (control: 1.719 MPa, treated: 4.134 MPa, p < 0.01). WAXS indicated that collagen molecular spacing (control: 1.485 nm/treated: 1.480 nm, p = 0.65), spatial disorder (47.6 a.u./47.6 a.u., p > 0.99), and anisotropy (0.935 a.u./1.157 a.u., p = 0.09) were not significantly affected by treatment. No marked treatment effects on collagen fibril bundle organization were observable by SHG imaging. TPF imaging revealed additional crimped fibrous structures in the outer half of the tissue depth in treated specimens, indicative of enhanced collagen cross-linking.
Conclusions: WST11/NIR treatment significantly increased the stiffness of the ex vivo rabbit sclera. The origin of the stiffening effect is consistent with the formation of collagen cross-links that are predominantly extrafibrillar in nature. Further research is needed to establish the full mechanism, efficacy, and safety of the method as a potential myopia treatment.
|
Mar 2026
|
|
I02-Macromolecular Crystallography
I03-Macromolecular Crystallography
I24-Microfocus Macromolecular Crystallography
|
Diamond Proposal Number(s):
[38316]
Open Access
Abstract: The DUF4465 family (DUF, domain of unknown function) contains more than 1000 members distributed across eight bacterial clades with species from diverse microenvironments including various gut microbiomes, hydrothermal vents, and soil. In the gut commensal Bacteroides thetaiotaomicron (B. theta), DUF4465 containing proteins act as high-affinity B12–binding proteins that scavenge this cofactor to ensure bacterial survival. Such B12 capture is essential for bacteria that have lost the ability to synthesize B12 de novo. This raises the question of whether B12-binding is ubiquitous across this family of proteins. Here, we show that B12-binding is a recurrent function of eight distantly related members of the DUF4465 family. It is reasonable to conclude that B12-binding is a common function of most DUF4465 proteins. These results establish DUF4465 as a structurally conserved family of augmented β-jellyroll B12-binding proteins with widespread roles in microbial competition for this essential cofactor.
|
Mar 2026
|
|
I02-Macromolecular Crystallography
|
Martin
Orecchia
,
Katherine
Welbeck
,
Jason
Dexter
,
Laura
Hook
,
Chika
Akinseye
,
Marcin
Kot
,
Alan
Lewis
,
Don
Somers
,
Tejinder
Bhinder
,
Paul
Hamblin
,
Sarah
Elsey
,
David
Willé
,
Steven
Grant
Open Access
Abstract: This study describes the affinity maturation, molecular engineering, and preclinical assessment of depemokimab, an enhanced anti-interleukin-5 antagonist antibody. The molecular design objective for depemokimab was to generate a therapeutic antibody enabling a less frequent dosing regimen of once every 6 months compared with every 4 weeks for mepolizumab. Mepolizumab is a marketed monoclonal antibody used as an add-on prescription maintenance treatment for patients with severe asthma with an eosinophilic phenotype and other eosinophilic-associated disorders. A complementarity-determining region restricted affinity maturation strategy was used where affinity improved interleukin-5 binding antibody variants were subject to affinity driven selective pressure and identified using the Adimab yeast-based platform. Improved complementarity-determining region variants were combined with serum half-life extending amino acid mutations introduced into the fragment crystallizable region of the antibody. When compared with mepolizumab, depemokimab demonstrated improved in vitro interleukin-5 neutralization in a TF-1 (human erythroleukemia) functional cell assay. In vivo, depemokimab displayed significantly extended pharmacokinetic performance and pharmacodynamic duration determined via eosinophil suppression in cynomolgus monkey (Macaca fascicularis). These data provide compelling evidence that a less frequent dosing regimen for depemokimab in humans is possible and supported the advancement of depemokimab into a Phase I study in patients with asthma.
|
Dec 2025
|
|
I02-Macromolecular Crystallography
|
Diamond Proposal Number(s):
[9948]
Open Access
Abstract: Copper is an essential micronutrient for bacteria, needed for important copper enzymes such as terminal respiratory oxidases. However, in excess, copper is toxic to bacteria. This toxicity is caused by its ability to bind tightly to proteins through the formation of Cu-Cys and Cu-His bonds. To control toxicity, bacteria have evolved homeostatic systems to safely handle the copper they need while efficiently sequestering and effluxing excess copper ions. We previously found that GapA, the abundant glycolytic glyceraldehyde-3-phosphate dehydrogenase enzyme in the Staphylococcus aureus cytosol, becomes associated with copper within cells cultured in medium containing excess copper. We found that this association of GapA with copper resulted in inhibition of its enzyme activity. Here, we have characterised this binding of copper ions to S. aureus GapA in vitro to determine the mechanism of copper inhibition of GAPDH. We found that purified recombinant GapA binds a single Cu(I) ion with high affinity. Crystallographic structural determination showed association of this copper ion with two active site residues, Cys151 and His178, known to be important for catalysis. This observation was confirmed by characterisation of mutated variants lacking these residues, which showed reduced ability to bind Cu(I) ions. Finally, we demonstrated that the cytosolic copper metallochaperone, CopZ, exhibits a tighter affinity for Cu(I) and can remove copper from GapA in vitro. Together, our data demonstrate the mechanism by which excess copper binds to the S. aureus GapA enzyme and irreversibly inhibit its activity and how the cellular homeostasis system is capable of resolving this inhibition.
|
Dec 2025
|
|